Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: Implications for disease histogenesis and pathogenesis

British Journal of Haematology

Volumn 111, Issue 1, 2000, Pages 247-257

  Carbone, Antonino ^a   Gloghini, Annunziata ^a   Cozzi, Maria Rita ^a   Capello, Daniela ^b   Steffan, Agostino ^a   Monini, Paolo ^c   De Marco, Luigi ^a   Gaidano, Gianluca ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Effusions; Histogenesis; Lymphomas; MUM1 IRF4; PEL

Indexed keywords

ANTIGEN; ANTIGEN 138; B LYMPHOCYTE ANTIGEN; GENE PRODUCT; INTERFERON REGULATORY FACTOR 4; PROTEIN MUM1; SYNDECAN; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; CELL DIFFERENTIATION; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENETIC VARIABILITY; HISTOGENESIS; HUMAN; HUMAN HERPESVIRUS 8; MALE; PATHOGENESIS; PHENOTYPE; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; BIOLOGICAL MARKERS; BLOTTING, WESTERN; BURKITT LYMPHOMA; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON REGULATORY FACTORS; LYMPH NODES; LYMPHOMA, B-CELL; MEMBRANE GLYCOPROTEINS; MODELS, IMMUNOLOGICAL; POINT MUTATION; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-6; SYNDECAN-1; SYNDECANS; TRANSCRIPTION FACTORS;

EID: 0033759012     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02329.x     Document Type: Article

References (53)

1. Primary body cavity-based AIDS-related lymphomas
2. Establishment and characterization of primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus
3. + cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCD mice
4. Assembly requirements of PU.1-Pip (IRF4) activator complexes: Inhibiting function in vivo using fused dimers
5. The tyrosine kinase receptor Met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphomas
6. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia
7. HHV-8-positive body cavity-based lymphoma: A novel lymphoma entity
8. Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AiDS-unrelated lymphomatous effusions
9. Establishment of HHV-8 positive and HHV-8 negative lymphoma cell lines from primary lymphomatous effusions
10. Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8
11. Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas
12. Characterization of a novel HHV-8 positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma
13. BCL-6 protein is expressed in germinal-center B cells
14. The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases
15. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas
16. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences
17. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes)
18. Lymphoma cell lines: In vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas)
19. Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas
20. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells
21. Molecular profile of Epstein-Barr virus infection in HHV-8 positive primary effusion lymphoma
22. Monoclonal antibodies PG-B6a and PG-B6b recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region
23. Primary effusion lymphoma. A liquid phase lymphoma of fluid-filled cavities
24. MUM1: A step ahead toward the understanding of lymphoma histogenesis
25. Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia
26. Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions
27. Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas
28. Association of KSHV positive primary effusion lymphoma with expression of the CD138/ syndecan-1 antigen
29. Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: Implications for disease pathogenesis and histogenesis
30. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway
31. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997
32. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies
33. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
34. Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient
35. Cellular origin of human B-cell lymphomas
36. Kaposis's sarcoma-associated herpesvirus viral interferon regulatory factor
37. Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation
38. Frequent somatic hypermutation of the 5' noncoding region of the bcl-6 gene in B-cell lymphoma
39. Requirement for the transcription factor LS/RF/IRF4 for mature B and T lymphocyte function
40. Molecular mimicry of human cytokine response pathway genes by KSHV
41. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus
42. The growing family of interferon regulatory factors
43. Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma
44. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies
45. BCL-6 mutations in normal germinal center B cells: Evidence of somatic hypermutation acting outside Ig loci
46. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture
47. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
48. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies
49. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1
50. Detection of MUM1/IRF4-IgH fusion in multiple myeloma
51. IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency
52. Interferon regulatory factor represses the Epstein-Barr virus BamHI Q latency promoter in Type III latency
53. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that repress IRF-1 mediated transcription